OPTUS Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	16,514	20,672	26,906	17,811	10,409	32,555
Short-Term Investments	-	-	24,000	40,000	40,000	42,000
Trading Asset Securities	18,190	19,124	502.41	10,711	11,146	-
Cash & Short-Term Investments	34,704	39,796	51,408	68,522	61,555	74,555
Cash Growth	-16.55%	-22.59%	-24.98%	11.32%	-17.44%	-9.52%
Accounts Receivable	10,930	11,027	13,492	9,321	7,472	6,313
Other Receivables	10,307	2,551	231.04	632.99	418.49	223.12
Receivables	21,250	13,593	13,753	9,995	7,908	6,564
Inventory	12,807	13,511	12,500	13,071	11,622	9,791
Prepaid Expenses	98.99	164.71	172.83	137.33	83.78	105.4
Other Current Assets	103.9	90.47	61.71	46.08	217.78	1
Total Current Assets	68,963	67,155	77,896	91,772	81,386	91,017
Property, Plant & Equipment	107,591	99,296	56,863	42,501	43,735	38,717
Long-Term Investments	3,367	6,349	13,740	13,497	10,121	9,636
Other Intangible Assets	15,249	15,467	16,066	-	-	-
Long-Term Accounts Receivable	-	-	-	-	-	-0
Long-Term Deferred Tax Assets	1,473	1,310	-	-	-	614.46
Other Long-Term Assets	1,168	1,477	1,928	1,647	963.78	53.31
Total Assets	197,815	191,057	166,503	149,460	136,240	140,038
Accounts Payable	1,288	2,239	3,124	1,889	1,536	1,519
Accrued Expenses	6,962	8,394	5,638	7,976	5,804	4,885
Current Portion of Leases	828.63	701.33	694.79	713.48	680.29	73.11
Current Income Taxes Payable	2,335	1,390	423.89	1,147	289.1	1,197
Other Current Liabilities	9,622	12,879	11,229	1,347	1,450	3,701
Total Current Liabilities	21,036	25,603	21,110	13,072	9,760	11,375
Long-Term Leases	549.23	271.11	758.87	1,359	1,918	167.1
Pension & Post-Retirement Benefits	-	0	-0	-	-	1,475
Long-Term Deferred Tax Liabilities	-	-	738.22	494.15	14.92	-
Other Long-Term Liabilities	184.84	176.63	161.73	83.75	79.51	0
Total Liabilities	21,770	26,051	22,768	15,009	11,773	13,018
Common Stock	9,029	9,029	8,282	8,282	8,282	8,282
Additional Paid-In Capital	50,753	45,826	36,601	36,553	36,663	36,663
Retained Earnings	118,186	115,685	103,978	95,689	86,636	85,281
Treasury Stock	-1,765	-5,469	-5,580	-5,751	-6,352	-3,068
Comprehensive Income & Other	-157.94	-65.47	453.44	-322.28	-762.48	-137.35
Shareholders' Equity	176,045	165,006	143,735	134,451	124,467	127,021
Total Liabilities & Equity	197,815	191,057	166,503	149,460	136,240	140,038
Total Debt	1,378	972.44	1,454	2,073	2,598	240.2
Net Cash (Debt)	33,326	38,824	49,955	66,450	58,956	74,315
Net Cash Growth	-17.36%	-22.28%	-24.82%	12.71%	-20.67%	-9.30%
Net Cash Per Share	2093.73	2497.73	3271.06	4372.19	3717.14	4635.53
Filing Date Shares Outstanding	16.75	16.8	15.29	15.26	15.17	16.04
Total Common Shares Outstanding	16.75	16.8	15.29	15.26	15.17	16.04
Working Capital	47,928	41,552	56,787	78,700	71,626	79,642
Book Value Per Share	10509.07	9823.75	9403.11	8811.11	8207.04	7918.38
Tangible Book Value	160,797	149,539	127,669	134,451	124,467	127,021
Tangible Book Value Per Share	9598.78	8902.93	8352.11	8811.11	8207.04	7918.38
Land	5,271	5,271	5,271	5,271	5,478	5,584
Buildings	18,464	18,625	19,266	19,188	19,938	16,130
Machinery	10,416	10,169	12,099	13,415	14,420	4,577
Construction In Progress	71,852	64,044	18,412	1,999	506.56	12,183